Author Archives: "Elizabeth Porco"

Elizabeth Porco

5 potential side effects of multiple sclerosis medications
Possible side effects for multiple sclerosis (MS) medications can range from mild to life-threatening.   When managing MS, health care [...]
New role of environment in multiple sclerosis revealed
Environmental factors may be playing a much greater role in the onset of multiple sclerosis (MS) than previously realised, according to [...]
Brain training video games ‘can soothe symptoms of multiple sclerosis’
Playing brain training video games can soothe symptoms of multiple sclerosis, say scientists. It boosts connections between neurons [...]
Can drinking lots of coffee lower risk for multiple scleorsis?
Coffee's possible health perks keep getting sweeter. In this case, a new study in the Journal of Neurology Neurosurgery & [...]
Ocrelizumab benefit in PPMS consistent in subgroups
NEW ORLEANS — A subgroup analysis of the phase 3 ORATORIO trial in primary progressive multiple sclerosis (PPMS) showed that ocrelizumab [...]
Wearable robotic exoskeleton may enable multiple sclerosis patients to walk more efficiently
Walking with a wearable robotic exoskeleton may enable people with multiple sclerosis to walk more efficiently by reducing the energy and [...]
Department of Defense Multiple Sclerosis Research Program FY16
NEWS RELEASE Released: February 18, 2016 Defense Health Program Department of Defense Multiple Sclerosis Research Program Funding [...]
In memoriam – Dr. Rossman
In Memoriam The Board of Governors and the administrative office of the CMSC are saddened to learn of the passing  of Dr. Howard [...]
FDA grants breakthrough therapy for Ocrelizumab for PPMS
Press Release FDA grants Breakthrough Therapy Designation for GENENTECH’s investigational medicine ocrelizumab in primary progressive [...]
Multiple sclerosis patients may lose ability to taste
Many patients with multiple sclerosis (MS) lose the ability to distinguish different tastes -- a signal associated with MS-related lesions [...]

CMSC provides leadership in clinical research and education; develops vehicles to share information and knowledge among members; disseminates information to the health care community and to persons affected by MS.

Contact Us
Contact Us
I have a question about
First
Last